OBJECTIVES: The Vitamin Intervention for Stroke Prevention trial found an association between baseline poststroke homocysteine (Hcy) and recurrent stroke. We investigated genes for enzymes and cofactors in the Hcy metabolic pathway for association with Hcy and determined whether associated single nucleotide polymorphisms (SNPs) influenced recurrent stroke risk. METHODS: Eighty-six SNPs in 9 candidate genes (BHMT1, BHMT2, CBS, CTH, MTHFR, MTR, MTRR, TCN1, and TCN2) were genotyped in 2,206 subjects (83% European American). Associations with Hcy measures were assessed using linear regression models assuming an additive genetic model, adjusting for age, sex, and race and additionally for baseline Hcy when postmethionine load change was assessed. Associations with recurrent stroke were evaluated using survival analyses. RESULTS: Five SNPs in the transcobalamin 2 (TCN2) gene were associated with baseline Hcy (false discovery rate [FDR]-adjusted p = 0.049). TCN2 SNP rs731991 was associated with recurrent stroke risk in the low-dose arm of the trial under a recessive model (log-rank test p = 0.009, hazard ratio 0.34). Associations with change in postmethionine load Hcy levels were found with 5 SNPs in the cystathionine β-synthase (CBS) gene (FDR-adjusted p < 0.031). CONCLUSIONS: TCN2 variants contribute to poststroke Hcy levels, whereas variants in the CBS gene influence Hcy metabolism. Variation in the TCN2 gene also affects recurrent stroke risk in response to cofactor therapy.
OBJECTIVES: The Vitamin Intervention for Stroke Prevention trial found an association between baseline poststroke homocysteine (Hcy) and recurrent stroke. We investigated genes for enzymes and cofactors in the Hcy metabolic pathway for association with Hcy and determined whether associated single nucleotide polymorphisms (SNPs) influenced recurrent stroke risk. METHODS: Eighty-six SNPs in 9 candidate genes (BHMT1, BHMT2, CBS, CTH, MTHFR, MTR, MTRR, TCN1, and TCN2) were genotyped in 2,206 subjects (83% European American). Associations with Hcy measures were assessed using linear regression models assuming an additive genetic model, adjusting for age, sex, and race and additionally for baseline Hcy when postmethionine load change was assessed. Associations with recurrent stroke were evaluated using survival analyses. RESULTS: Five SNPs in the transcobalamin 2 (TCN2) gene were associated with baseline Hcy (false discovery rate [FDR]-adjusted p = 0.049). TCN2 SNP rs731991 was associated with recurrent stroke risk in the low-dose arm of the trial under a recessive model (log-rank test p = 0.009, hazard ratio 0.34). Associations with change in postmethionine load Hcy levels were found with 5 SNPs in the cystathionine β-synthase (CBS) gene (FDR-adjusted p < 0.031). CONCLUSIONS:TCN2 variants contribute to poststroke Hcy levels, whereas variants in the CBS gene influence Hcy metabolism. Variation in the TCN2 gene also affects recurrent stroke risk in response to cofactor therapy.
Authors: Kevin L Gunderson; Semyon Kruglyak; Michael S Graige; Francisco Garcia; Bahram G Kermani; Chanfeng Zhao; Diping Che; Todd Dickinson; Eliza Wickham; Jim Bierle; Dennis Doucet; Monika Milewski; Robert Yang; Chris Siegmund; Juergen Haas; Lixin Zhou; Arnold Oliphant; Jian-Bing Fan; Steven Barnard; Mark S Chee Journal: Genome Res Date: 2004-04-12 Impact factor: 9.043
Authors: M J Stampfer; M R Malinow; W C Willett; L M Newcomer; B Upson; D Ullmann; P V Tishler; C H Hennekens Journal: JAMA Date: 1992-08-19 Impact factor: 56.272
Authors: A G Bostom; D Shemin; K L Lapane; M R Nadeau; P Sutherland; J Chan; R Rozen; D Yoburn; P F Jacques; J Selhub; I H Rosenberg Journal: Atherosclerosis Date: 1996-06 Impact factor: 5.162
Authors: L A Kluijtmans; G H Boers; E M Stevens; W O Renier; J P Kraus; F J Trijbels; L P van den Heuvel; H J Blom Journal: J Clin Invest Date: 1996-07-15 Impact factor: 14.808
Authors: P Frosst; H J Blom; R Milos; P Goyette; C A Sheppard; R G Matthews; G J Boers; M den Heijer; L A Kluijtmans; L P van den Heuvel Journal: Nat Genet Date: 1995-05 Impact factor: 38.330
Authors: James F Toole; M René Malinow; Lloyd E Chambless; J David Spence; L Creed Pettigrew; Virginia J Howard; Elizabeth G Sides; Chin-Hua Wang; Meir Stampfer Journal: JAMA Date: 2004-02-04 Impact factor: 56.272
Authors: N Pancharuniti; C A Lewis; H E Sauberlich; L L Perkins; R C Go; J O Alvarez; M Macaluso; R T Acton; R B Copeland; A L Cousins Journal: Am J Clin Nutr Date: 1994-04 Impact factor: 7.045
Authors: P F Jacques; A G Bostom; R R Williams; R C Ellison; J H Eckfeldt; I H Rosenberg; J Selhub; R Rozen Journal: Circulation Date: 1996-01-01 Impact factor: 29.690
Authors: Jung-Ying Tzeng; Daowen Zhang; Monnat Pongpanich; Chris Smith; Mark I McCarthy; Michèle M Sale; Bradford B Worrall; Fang-Chi Hsu; Duncan C Thomas; Patrick F Sullivan Journal: Am J Hum Genet Date: 2011-08-12 Impact factor: 11.025
Authors: Nicholas J Marini; Wei Yang; Kripa Asrani; John S Witte; Jasper Rine; Edward J Lammer; Gary M Shaw Journal: Am J Med Genet A Date: 2016-09-08 Impact factor: 2.802
Authors: Han Sung Park; Jung Oh Kim; Hui Jeong An; Chang Soo Ryu; Eun Ju Ko; Young Ran Kim; Eun Hee Ahn; Woo Sik Lee; Ji Hyang Kim; Nam Keun Kim Journal: J Assist Reprod Genet Date: 2019-05-23 Impact factor: 3.412
Authors: Shimul Chowdhury; Charlotte A Hobbs; Stewart L MacLeod; Mario A Cleves; Stepan Melnyk; S Jill James; Ping Hu; Stephen W Erickson Journal: Mol Genet Metab Date: 2012-09-27 Impact factor: 4.797
Authors: Keith L Keene; Wei-Min Chen; Fang Chen; Stephen R Williams; Stacey D Elkhatib; Fang-Chi Hsu; Josyf C Mychaleckyj; Kimberly F Doheny; Elizabeth W Pugh; Hua Ling; Cathy C Laurie; Stephanie M Gogarten; Ebony B Madden; Bradford B Worrall; Michele M Sale Journal: Front Public Health Date: 2014-08-06